PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2021/55 - Coloplast / Atos Medical
Acquired
Atos Medical Holding AB
Description
Multinational company of Swedish origin, which develops, manufactures and markets medical devices and services related to the treatment of laryngectomy and tracheostomy, namely HMEs (Heat and Moisture Exchangers), HME adhesives and voice prostheses. marketing of other ENT products (Ear, Nose and Throat).
Acquiring
Coloplast A/S
Description
Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy care, continence care, interventional urology and wound and skin care.
Sector
  • Supply and Food Industry
Activity (NACE)
  • G4690 - Non-specialised wholesale trade
Applicable legislation
Art. 37(1)(a) (Law 19)
Notification thresholds
Market Share threshold
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description
The notified concentration consists of the acquisition of sole control over Atos Medical Holding AB by Coloplast.
Timeline
2022-01-07
The AdC issued a non-opposition decision to the merger 55/2021 - Coloplast / Atos Medical
2021-12-13
Coloplast notifies the acquisition of sole control over Atos Medical.
Click here to see your activities